 |
poly-N,N’-hexamethyleneguanidine-poly-N1,N4-hexamethyleneaminoguanidine |
|---|---|
| Trade Name | |
| Orphan Indication | Cystic fibrosis |
| USA Market Approval | USA |
| USA Designation Date | 2016-04-05 00:00:00 |
| Sponsor | TGV-Inhalonix, Inc.;303 5th Avenue, Suite 2012;New York, New York, 10016 |
Related Access Program